Lenz Therapeutics

(NASDAQ) LENZ

Current Price$8.85

Market Cap$278.43M

Since IPO (2024)-45%

5 YearN/A

1 Year-69%

1 Month-5%

Lenz Therapeutics Financials at a Glance

Market Cap

$278.43M

Revenue (TTM)

$19.09M

Net Income (TTM)

$82.13M

EPS (TTM)

$-2.80

P/E Ratio

-3.17

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$8.85

Volume

32,880

Open

$8.96

Price

$8.85

Volume

32,880

Open

$8.96

Previous Close

$8.85

Daily Range

$8.75 - $9.10

52-Week Range

$8.25 - $50.40

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$8.85

Volume

32,880

Open

$8.96

Previous Close

$8.85

Daily Range

$8.75 - $9.10

52-Week Range

$8.25 - $50.40

LENZ News

Why Lenz Therapeutics Stock Plummeted by Almost 20% This Week

Eric VolkmanMar 27, 2026

Chart shows a red dollar sign trending down.

Why Lenz Therapeutics Stock Crashed Today

Rich SmithMar 24, 2026

Lenz (LENZ) Q2 Revenue Jumps 604%

Motley Fool Markets TeamJul 31, 2025

LENZ: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lenz Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

152

CEO

Evert B. Schimmelpennink

Website

www.lenz-tx.com

Headquarters

Solana Beach, CA 92014, US

LENZ Financials

Key Financial Metrics (TTM)

Gross Margin

97%

Operating Margin

-5%

Net Income Margin

-4%

Return on Equity

-34%

Return on Capital

-32%

Return on Assets

-27%

Earnings Yield

-31.55%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$278.43M

Shares Outstanding

31.35M

Volume

32.88K

Avg. Volume

919.77K

Financials (TTM)

Gross Profit

$18.67M

Operating Income

$91.14M

EBITDA

$91.14M

Operating Cash Flow

$69.17M

Capital Expenditure

$827.00K

Free Cash Flow

$70.00M

Cash & ST Invst.

$292.35M

Total Debt

$350.00K

Lenz Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$1.59M

N/A

Gross Profit

$1.17M

N/A

Gross Margin

73.68%

N/A

Market Cap

$278.43M

N/A

Market Cap/Employee

$46.40M

N/A

Employees

N/A

Net Income

$35.90M

-183.7%

EBITDA

$38.46M

-153.0%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$292.00M

+40.6%

Accounts Receivable

$2.43M

N/A

Inventory

$0.00

N/A

Long Term Debt

$350.00K

-57.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-26.85%

N/A

Return on Invested Capital

-32.01%

N/A

Free Cash Flow

$33.06M

-258.3%

Operating Cash Flow

$33.02M

-263.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RZLTRezolute, Inc.

RZLTRezolute, Inc.$3.30+3.13%

PRMEPrime Medicine, Inc.

PRMEPrime Medicine, Inc.$3.41-3.81%

SPRYARS Pharmaceuticals, Inc.

SPRYARS Pharmaceuticals, Inc.$8.56+3.63%

ABUSArbutus Biopharma Corporation

ABUSArbutus Biopharma Corporation$4.32+2.86%

GERNGeron Corporation

GERNGeron Corporation$1.58+2.60%

MRVIMaravai LifeSciences Holdings, Inc.

MRVIMaravai LifeSciences Holdings, Inc.$3.73+1.36%

SVRASavara Inc.

SVRASavara Inc.$5.12-2.29%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About LENZ

What is the current price of Lenz Therapeutics?

Lenz Therapeutics is trading at $8.85 per share.

What is the 52-week range for Lenz Therapeutics?

Over the past 52 weeks, Lenz Therapeutics has traded between $8.25 and $50.40.

How much debt does Lenz Therapeutics have?

As of the most recent reporting period, Lenz Therapeutics reported total debt of $815,000.

How much cash does Lenz Therapeutics have on hand?

Lenz Therapeutics reported $25.18M in cash and cash equivalents in its most recent financial results.

What is Lenz Therapeutics’s dividend yield?

Lenz Therapeutics does not currently have a dividend yield.

Lenz Therapeutics

Lenz Therapeutics Financials at a Glance

LENZ News

Why Lenz Therapeutics Stock Plummeted by Almost 20% This Week

Why Lenz Therapeutics Stock Crashed Today

Lenz (LENZ) Q2 Revenue Jumps 604%

LENZ: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Lenz Therapeutics

LENZ Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Lenz Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LENZ

What is the current price of Lenz Therapeutics?

What is the 52-week range for Lenz Therapeutics?

How much debt does Lenz Therapeutics have?

How much cash does Lenz Therapeutics have on hand?

What is Lenz Therapeutics’s dividend yield?

Premium Investing Services